These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9753176)

  • 1. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.
    Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J
    Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic proteins in Alzheimer's disease.
    Marksteiner J; Kaufmann WA; Gurka P; Humpel C
    J Mol Neurosci; 2002; 18(1-2):53-63. PubMed ID: 11931350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of calretinin-positive neurons are abnormal in Alzheimer's disease.
    Brion JP; Résibois A
    Acta Neuropathol; 1994; 88(1):33-43. PubMed ID: 7941970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretoneurin: a market in rat hippocampal pathways.
    Schwarzer C; Marksteiner J; Kroesen S; Kohl C; Sperk G; Winkler H
    J Comp Neurol; 1997 Jan; 377(1):29-40. PubMed ID: 8986870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin peptides in Alzheimer's disease.
    Lechner T; Adlassnig C; Humpel C; Kaufmann WA; Maier H; Reinstadler-Kramer K; Hinterhölzl J; Mahata SK; Jellinger KA; Marksteiner J
    Exp Gerontol; 2004 Jan; 39(1):101-13. PubMed ID: 14724070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of chromogranin A, chromogranin B and secretoneurin protein expression after transient forebrain ischemia in the gerbil.
    Martí E; Ferrer I; Blasi J
    Acta Neuropathol; 2001 Feb; 101(2):159-66. PubMed ID: 11271371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease.
    Marksteiner J; Lechner T; Kaufmann WA; Gurka P; Humpel C; Nowakowski C; Maier H; Jellinger KA
    Acta Neuropathol; 2000 Aug; 100(2):205-12. PubMed ID: 10963369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions.
    Marksteiner J; Saria A; Kirchmair R; Pycha R; Benesch H; Fischer-Colbrie R; Haring C; Maier H; Ransmayr G
    Eur J Neurosci; 1993 Dec; 5(12):1573-85. PubMed ID: 7510203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease.
    Mikkonen M; Alafuzoff I; Tapiola T; Soininen H; Miettinen R
    Neuroscience; 1999; 92(2):515-32. PubMed ID: 10408601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical Characterization of PSA-NCAM
    Murray HC; Swanson MEV; Dieriks BV; Turner C; Faull RLM; Curtis MA
    Neuroscience; 2018 Feb; 372():289-303. PubMed ID: 29429526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human brain stem.
    Marksteiner J; Saria A; Hinterhuber H
    J Chem Neuroanat; 1994 Oct; 7(4):253-70. PubMed ID: 7532949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat.
    Marksteiner J; Lassnig E; Telser S; Kroesen S; Kirchmair R; Fischer-Colbrie R; Miller C; Saria A
    J Comp Neurol; 1995 Mar; 353(2):275-90. PubMed ID: 7745136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala.
    Kaufmann WA; Barnas U; Maier J; Saria A; Alheid GF; Marksteiner J
    Synapse; 1997 Jun; 26(2):114-30. PubMed ID: 9131771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry.
    Yao PJ; Morsch R; Callahan LM; Coleman PD
    Neuroscience; 1999; 94(2):389-94. PubMed ID: 10579202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin immunoreactivity in the monkey hippocampal formation--I. Light and electron microscopic characteristics and co-localization with other calcium-binding proteins.
    Seress L; Nitsch R; Leranth C
    Neuroscience; 1993 Aug; 55(3):775-96. PubMed ID: 8413936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
    Wakabayashi K; Honer WG; Masliah E
    Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranins in temporal lobe epilepsy.
    Kandlhofer S; Hoertnagl B; Czech T; Baumgartner C; Maier H; Novak K; Sperk G
    Epilepsia; 2000; 41 Suppl 6():S111-4. PubMed ID: 10999531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic and neuritic alterations during the progression of Alzheimer's disease.
    Masliah E; Mallory M; Hansen L; DeTeresa R; Alford M; Terry R
    Neurosci Lett; 1994 Jun; 174(1):67-72. PubMed ID: 7970158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus.
    Blasco-Ibáñez JM; Freund TF
    Hippocampus; 1997; 7(3):307-20. PubMed ID: 9228528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of calretinin immunoreactivity in the mouse dentate gyrus: II. Mossy cells, with special reference to their dorsoventral difference in calretinin immunoreactivity.
    Fujise N; Liu Y; Hori N; Kosaka T
    Neuroscience; 1998 Jan; 82(1):181-200. PubMed ID: 9483514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.